Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of liraglutide on hypoglycaemia counterregulation and pulsatile insulin secretion
2010-023107-10Phase 4Terminated
- Sponsor
- St. Josef-Hospital Bochum
- Start
- Jun 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by St. Josef-Hospital Bochum. Primary endpoints: Concentrations of insulin, Concentrations of C-peptide and 1 more. Started Jun 2012; status: terminated.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-023107-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023107-10.